☆ 4.7 Article

Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects

NEUROPSYCHOPHARMACOLOGY (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Pharmacology & Pharmacy

Acute Effects of Psilocybin After Escitalopram or Placebo Pretreatment in a Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Healthy Subjects

Anna M. Becker et al.

Summary: The study examined the interaction between escitalopram and psilocybin in the treatment of depression and anxiety. Escitalopram pretreatment was found to reduce certain negative effects of psilocybin, but further research is needed to fully understand the interactions between antidepressants and psilocybin in patients with psychiatric disorders.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2022)

添加到收藏夹

Article Neurosciences

Safety pharmacology of acute LSD administration in healthy subjects

Friederike Holze et al.

Summary: This study found that LSD has dose-dependent subjective, physiological, and adverse effects. Most subjects reported good drug effects at doses of 50 μg and above, but also experienced negative effects. The physiological effects of LSD were moderate, with no serious psychological or physical harm observed.

PSYCHOPHARMACOLOGY (2022)

添加到收藏夹

Article Neurosciences

Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects

Friederike Holze et al.

Summary: This study evaluated the subjective and autonomic effects of different doses of LSD in healthy subjects. It found that LSD displayed dose-proportional pharmacokinetics and dose-dependently induced subjective responses, with a ceiling effect observed for good drug effects at 100 μg. The results suggest that future LSD research may benefit from dose finding based on these findings, and that the full psychedelic effects of LSD are primarily mediated by serotonin 5-HT2A receptor activation.

NEUROPSYCHOPHARMACOLOGY (2021)

添加到收藏夹

Article Biochemical Research Methods

Development and validation of an LC-MS/MS method for the bioanalysis of psilocybin ' s main metabolites, psilocin and 4-hydroxyindole-3-acetic acid, in human plasma

Karolina E. Kolaczynska et al.

Summary: A rapid LC-MS/MS method was developed and validated for quantifying psilocin and its metabolite 4-HIAA in human plasma, showing good accuracy and precision over three validation runs. This method could assess the pharmacokinetics of psilocin and 4-HIAA and facilitate the clinical development of psilocybin.

JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2021)

添加到收藏夹

Article Clinical Neurology

Optimal dosing for psilocybin pharmacotherapy: Considering weight-adjusted and fixed dosing approaches

Albert Garcia-Romeu et al.

Summary: The study found that the subjective effects of psilocybin were not affected by body weight when administered either on a weight-adjusted basis or as a fixed dose. The convenience and lower cost of administering psilocybin as a fixed dose outweigh any potential advantages of weight-adjusted dosing.

JOURNAL OF PSYCHOPHARMACOLOGY (2021)

添加到收藏夹

Article Medicine, General & Internal

Trial of Psilocybin versus Escitalopram for Depression

Robin Carhart-Harris et al.

Summary: The study compared the efficacy of psilocybin and escitalopram in treating patients with major depressive disorder. While there was no significant difference in antidepressant effects between the two drugs at week 6, secondary outcomes generally favored psilocybin over escitalopram, though these results were not adjusted for multiple comparisons. Larger and longer trials are needed to further compare psilocybin with established antidepressants.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Psychiatry

Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder A Randomized Clinical Trial

Alan K. Davis et al.

Summary: The study showed that psilocybin therapy with psychological support is effective in treating MDD, building on previous findings in patients with cancer and depression, as well as in a nonrandomized study in patients with treatment-resistant depression.

JAMA PSYCHIATRY (2021)

添加到收藏夹

Article Pharmacology & Pharmacy

Role of the 5-HT2A Receptor in Acute Effects of LSD on Empathy and Circulating Oxytocin

Friederike Holze et al.

Summary: The study found that LSD can enhance empathy with dose-dependent effects on emotional empathy and also increase plasma oxytocin levels, partially independent of the primary action on 5-HT2A receptors. These findings provide important implications for further research investigating the therapeutic effects of LSD in patients with empathy deficits and impairments in social functioning.

FRONTIERS IN PHARMACOLOGY (2021)

添加到收藏夹

Article Chemistry, Medicinal

Low Doses of LSD Acutely Increase BDNF Blood Plasma Levels in Healthy Volunteers

Nadia R. P. W. Hutten et al.

Summary: The study found that single low doses of LSD can significantly increase BDNF levels in healthy volunteers in a short period of time, providing a new direction for researching the use of LSD in patient populations.

ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2021)

添加到收藏夹

Article Clinical Neurology

Exploratory Controlled Study of the Migraine-Suppressing Effects of Psilocybin

Emmanuelle A. D. Schindler et al.

Summary: An exploratory study found that a single administration of psilocybin had a lasting therapeutic effect on migraine headaches, separate from its acute psychotropic effects. This highlights the importance of further investigating the clinical effects of select 5-HT2A receptor compounds in migraine and other neuropsychiatric conditions.

NEUROTHERAPEUTICS (2021)

添加到收藏夹

Article Neurosciences

Distinct acute effects of LSD, MDMA, and d-amphetamine in healthy subjects

Friederike Holze et al.

NEUROPSYCHOPHARMACOLOGY (2020)

添加到收藏夹

Article Pharmacology & Pharmacy

Pharmacokinetics and subjective effects of a novel oral LSD formulation in healthy subjects

Friederike Holze et al.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2019)

添加到收藏夹

Article Neurosciences

Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels

Martin K. Madsen et al.

NEUROPSYCHOPHARMACOLOGY (2019)

添加到收藏夹

Article Psychology, Multidisciplinary

Modulation of Serum Brain-Derived Neurotrophic Factor by a Single Dose of Ayahuasca: Observation From a Randomized Controlled Trial

Raissa Nobrega de Almeida et al.

FRONTIERS IN PSYCHOLOGY (2019)

添加到收藏夹

Article Neurosciences

Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: similarities and differences in subjective experiences

Theresa M. Carbonaro et al.

PSYCHOPHARMACOLOGY (2018)

添加到收藏夹

Article Clinical Neurology

High dose psilocybin is associated with positive subjective effects in healthy volunteers

Christopher R. Nicholas et al.

JOURNAL OF PSYCHOPHARMACOLOGY (2018)

添加到收藏夹

Article Cell Biology

Psychedelics Promote Structural and Functional Neural Plasticity

Calvin Ly et al.

CELL REPORTS (2018)

添加到收藏夹

Article Pharmacology & Pharmacy

Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression

Leor Roseman et al.

FRONTIERS IN PHARMACOLOGY (2018)

添加到收藏夹

Article Neurosciences

Alterations of consciousness and mystical-type experiences after acute LSD in humans

Matthias E. Liechti et al.

PSYCHOPHARMACOLOGY (2017)

添加到收藏夹

Review Neurosciences

Modern Clinical Research on LSD

Matthias E. Liechti

NEUROPSYCHOPHARMACOLOGY (2017)

添加到收藏夹

Article Pharmacology & Pharmacy

Pharmacokinetics of Escalating Doses of Oral Psilocybin in Healthy Adults

Randall T. Brown et al.

CLINICAL PHARMACOKINETICS (2017)

添加到收藏夹

Article Pharmacology & Pharmacy

Pharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide in Healthy Subjects

Patrick C. Dolder et al.

CLINICAL PHARMACOKINETICS (2017)

添加到收藏夹

Article Biochemistry & Molecular Biology

The Fabric of Meaning and Subjective Effects in LSD-Induced States Depend on Serotonin 2A Receptor Activation

Katrin H. Preller et al.

CURRENT BIOLOGY (2017)

添加到收藏夹

Article Clinical Neurology

Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens

Anna Rickli et al.

EUROPEAN NEUROPSYCHOPHARMACOLOGY (2016)

添加到收藏夹

Article Clinical Neurology

Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial

Roland R. Griffiths et al.

JOURNAL OF PSYCHOPHARMACOLOGY (2016)

添加到收藏夹

Article Clinical Neurology

Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial

Stephen Ross et al.

JOURNAL OF PSYCHOPHARMACOLOGY (2016)

添加到收藏夹

Article Psychiatry

Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study

Robin L. Carhart-Harris et al.

LANCET PSYCHIATRY (2016)

添加到收藏夹

Article Neurosciences

Acute Effects of Lysergic Acid Diethylamide in Healthy Subjects

Yasmin Schmid et al.

BIOLOGICAL PSYCHIATRY (2015)

添加到收藏夹

Article Clinical Neurology

Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin

Frederick S. Barrett et al.

JOURNAL OF PSYCHOPHARMACOLOGY (2015)

添加到收藏夹

Article Clinical Neurology

LSD-assisted psychotherapy for anxiety associated with a life-threatening disease: A qualitative study of acute and sustained subjective effects

Peter Gasser et al.

JOURNAL OF PSYCHOPHARMACOLOGY (2015)

添加到收藏夹

Article Clinical Neurology

Plasma brain derived neurotrophic factor (BDNF) and response to ketamine in treatment-resistant depression

C. N. Haile et al.

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2014)

添加到收藏夹

Article Multidisciplinary Sciences

No Evidence that MDMA-Induced Enhancement of Emotional Empathy Is Related to Peripheral Oxytocin Levels or 5-HT1a Receptor Activation

Kim P. C. Kuypers et al.

PLOS ONE (2014)

添加到收藏夹

Article Clinical Neurology

Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies

Erich Studerus et al.

JOURNAL OF PSYCHOPHARMACOLOGY (2011)

添加到收藏夹

Article Neurosciences

Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects

Roland R. Griffiths et al.

PSYCHOPHARMACOLOGY (2011)

添加到收藏夹

Article Emergency Medicine

Effects of a β-blocker on the cardiovascular response to MDMA (Ecstasy)

C. M. Hysek et al.

EMERGENCY MEDICINE JOURNAL (2010)

添加到收藏夹

Article Multidisciplinary Sciences

Psychometric Evaluation of the Altered States of Consciousness Rating Scale (OAV)

Erich Studerus et al.

PLOS ONE (2010)

添加到收藏夹

Article Neurosciences

Dopamine D4 receptor involvement in the discriminative stimulus effects in rats of LSD, but not the phenethylamine hallucinogen DOI

Danuta Marona-Lewicka et al.

PSYCHOPHARMACOLOGY (2009)

添加到收藏夹

Article Neurosciences

Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance

R. R. Griffiths et al.

PSYCHOPHARMACOLOGY (2006)

添加到收藏夹

Article Neurosciences

Distinct temporal phases in the behavioral pharmacology of LSD:: dopamine D2 receptor-mediated effects in the rat and implications for psychosis

D Marona-Lewicka et al.

PSYCHOPHARMACOLOGY (2005)

添加到收藏夹

Article Neurosciences

Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose-effect study

F Hasler et al.

PSYCHOPHARMACOLOGY (2004)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.